Bogart Wealth LLC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.4M | Buy |
67,429
+275
| +0.4% | +$38.5K | 0.36% | 63 |
|
|
2025
Q4 | $8.24M | Sell |
67,154
-934
| -1% | -$114K | 0.33% | 69 |
|
|
2025
Q3 | $7.56M | Sell |
68,088
-1,162
| -2% | -$132K | 0.31% | 79 |
|
|
2025
Q2 | $7.68M | Buy |
69,250
+1,815
| +3% | +$193K | 0.33% | 71 |
|
|
2025
Q1 | $7.56M | Sell |
67,435
-23,130
| -26% | -$2.39M | 0.36% | 66 |
|
|
2024
Q4 | $8.37M | Sell |
90,565
-2,218
| -2% | -$200K | 0.4% | 62 |
|
|
2024
Q3 | $7.78M | Sell |
92,783
-1,523
| -2% | -$116K | 0.37% | 62 |
|
|
2024
Q2 | $6.47M | Buy |
94,306
+19,668
| +26% | +$1.31M | 0.33% | 71 |
|
|
2024
Q1 | $5.47M | Buy |
74,638
+957
| +1% | +$73.6K | 0.28% | 84 |
|
|
2023
Q4 | $5.97M | Sell |
73,681
-1,070
| -1% | -$83.3K | 0.34% | 75 |
|
|
2023
Q3 | $5.6M | Sell |
74,751
-49
| -0.1% | -$3.77K | 0.35% | 73 |
|
|
2023
Q2 | $5.76M | Buy |
74,800
+994
| +1% | +$79.3K | 0.37% | 69 |
|
|
2023
Q1 | $6.12M | Buy |
73,806
+2,959
| +4% | +$245K | 0.41% | 61 |
|
|
2022
Q4 | $6.08M | Sell |
70,847
-60,279
| -46% | -$4.77M | 0.42% | 53 |
|
|
2022
Q3 | $8.09M | Buy |
131,126
+16,551
| +14% | +$1.04M | 0.68% | 31 |
|
|
2022
Q2 | $7.08M | Buy |
114,575
+16,913
| +17% | +$1.05M | 0.62% | 37 |
|
|
2022
Q1 | $5.81M | Buy |
97,662
+14,216
| +17% | +$909K | 0.5% | 43 |
|
|
2021
Q4 | $6.06M | Buy |
83,446
+5,620
| +7% | +$387K | 0.55% | 39 |
|
|
2021
Q3 | $5.44M | Buy |
77,826
+5,979
| +8% | +$420K | 0.55% | 40 |
|
|
2021
Q2 | $4.95M | Buy |
71,847
+11,425
| +19% | +$763K | 0.54% | 37 |
|
|
2021
Q1 | $3.9M | Buy |
60,422
+18,874
| +45% | +$1.22M | 0.54% | 40 |
|
|
2020
Q4 | $2.42M | Buy |
41,548
+4,636
| +13% | +$280K | 0.45% | 39 |
|
|
2020
Q3 | $2.33M | Sell |
36,912
-273
| -0.7% | -$18.9K | 0.52% | 35 |
|
|
2020
Q2 | $2.86M | Buy |
37,185
+3,591
| +11% | +$275K | 0.67% | 26 |
|
|
2020
Q1 | $2.51M | Sell |
33,594
-120
| -0.4% | -$8.29K | 0.68% | 24 |
|
|
2019
Q4 | $2.19M | Buy |
33,714
+33,667
| +71,632% | +$2.19M | 0.7% | 36 |
|
|
2019
Q3 | $3K | Sell |
47
-21
| -31% | -$1.37K | ﹤0.01% | 322 |
|
|
2019
Q2 | $4K | Sell |
68
-23
| -25% | -$1.51K | ﹤0.01% | 289 |
|
|
2019
Q1 | $5K | Buy |
91
+1
| +1% | +$66 | ﹤0.01% | 281 |
|
|
2018
Q4 | $5K | Sell |
90
-1
| -1% | -$70 | ﹤0.01% | 279 |
|
|
2018
Q3 | $7K | Buy |
91
+22
| +32% | +$1.66K | ﹤0.01% | 246 |
|
|
2018
Q2 | $4K | Sell |
69
-1
| -1% | -$71 | ﹤0.01% | 291 |
|
|
2018
Q1 | $5K | Sell |
70
-46
| -40% | -$3.66K | ﹤0.01% | 280 |
|
|
2017
Q4 | $8K | Sell |
116
-765
| -87% | -$58.1K | 0.01% | 250 |
|
|
2017
Q3 | $72K | Buy |
+881
| New | +$67.4K | 0.05% | 107 |
|
Other funds holding GILD
VCM
VPM
Bogart Wealth LLC's GILD Position: Q1 2026 in Review
Bogart Wealth LLC increased its Gilead Sciences (GILD) stake by 0.41% in Q1 2026, buying an estimated $38.5K and bringing the position to 67,429 shares worth $9.4M. The position accounts for 0.36% of the portfolio, ranked #63.
Bogart Wealth LLC first reported a position in GILD in Q3 2017 and has held it in 35 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bogart Wealth LLC held 67,429 shares of Gilead Sciences worth $9.4M as of Q1 2026.
- Bogart Wealth LLC bought 275 Gilead Sciences shares in Q1 2026, an estimated $38.5K.
- Gilead Sciences made up 0.36% of Bogart Wealth LLC's portfolio in Q1 2026, its #63 holding.
- Bogart Wealth LLC first reported a position in Gilead Sciences in Q3 2017 and has held it in 35 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.